Kıvılcım (Spark) Yamanoglu

Kıvılcım (Spark) Yamanoglu has a diverse background in clinical research and operations. Their most recent position was as a Senior Clinical Operations Manager at Calyxo, Inc., starting in November 2020. Prior to that, they worked as a Senior Clinical Research Associate at CR Bard from December 2018 to November 2020.

Yamanoglu has experience in various roles at different companies. Kıvılcım (Spark) worked as a Clinical Research Associate at Solace Therapeutics from August 2014 to December 2018, where they served as the lead CRA for a pivotal trial and managed 11 domestic sites. Kıvılcım (Spark) also worked as a Clinical Research Associate at T2 Biosystems from February 2013 to July 2014, where they managed activities at 6 sites and was a senior CRA for a pivotal trial. Before that, they worked as a Clinical Research Coordinator at Mayo Clinic from December 2011 to February 2013, where they managed Phase I oncology trials and contributed to research study design discussions.

Yamanoglu also gained experience as a Clinical Research Coordinator at Gynecological Surgeon's Clinic from October 2008 to December 2011, where they worked under the direction of the clinical Principal Investigator and collaborated on regulatory submission documents. Kıvılcım (Spark) started their career as a Clinical Research Associate at Interlace Medical in 2010, where they performed site initiation and monitoring visits and provided site training.

Overall, Yamanoglu has a strong background in clinical research and operations, with experience in managing trials, training sites, and collaborating on regulatory submissions.

Kıvılcım (Spark) Yamanoglu pursued their Bachelor's degree in Business Administration and Management from Eastern Michigan University from 2004 to 2008.